These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 30488199)

  • 41. Apolipoprotein E polymorphism and lipoprotein compositions in patients with Behçet's disease.
    Tursen U; Eskandari G; Kaya TI; Tamer L; Ikizoglu G; Atik U
    Int J Dermatol; 2004 Dec; 43(12):900-3. PubMed ID: 15569012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population.
    Gajra B; Candlish JK; Saha N; Heng CK; Soemantri AG; Tay JS
    Genet Epidemiol; 1994; 11(1):19-27. PubMed ID: 8013886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status.
    Malavazi I; Abrão EP; Mikawa AY; Landgraf VO; da Costa PI
    Clin Chem Lab Med; 2004 May; 42(5):525-32. PubMed ID: 15202789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E epsilon4-carrying free-living individuals.
    Loktionov A; Scollen S; McKeown N; Bingham SA
    Br J Nutr; 2000 Dec; 84(6):885-90. PubMed ID: 11177205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [DNA polymorphism in the region of APOB100, APOCIII, APOE, and angiotensin-converting enzyme genes and indicators of the lipid spectrum in children and adolescents in St. Petersburg].
    Skobeleva NA; Vasina VI; Volkova MV; Sverdlova AM; Fomicheva EV; Obraztsova GI; Talalaeva EI; Shakir Kh; Laasri M; Vorontsov IM; Kovalev IuP; Shvarts EI
    Mol Gen Mikrobiol Virusol; 1997; (4):36-40. PubMed ID: 9411220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population.
    Masemola ML; Alberts M; Urdal P
    Scand J Public Health Suppl; 2007 Aug; 69():60-5. PubMed ID: 17676504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pediatric reference data of serum lipids and prevalence of dyslipidemia: Results from a population-based cohort in Germany.
    Dathan-Stumpf A; Vogel M; Hiemisch A; Thiery J; Burkhardt R; Kratzsch J; Kiess W
    Clin Biochem; 2016 Jul; 49(10-11):740-9. PubMed ID: 26948098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men.
    Liu S; Song Y; Hu FB; Niu T; Ma J; Gaziano M; Stampfer MJ
    Atherosclerosis; 2004 Nov; 177(1):119-26. PubMed ID: 15488874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Editorial: designing targeted sequencing panels for dyslipidemia.
    Hegele RA
    Curr Opin Lipidol; 2019 Apr; 30(2):53-55. PubMed ID: 30664017
    [No Abstract]   [Full Text] [Related]  

  • 51. Prognostic Risk Models for the Development of Cardiovascular Dysfunction in Adolescents with Essential Hypertension.
    Kosovtseva AS; Bairova ТА; Rychkova LV; Polyakov VM; Kolesnikova LI
    Bull Exp Biol Med; 2019 Feb; 166(4):494-496. PubMed ID: 30783836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of the apolipoprotein E Arg145Cys dyslipidemia at-risk polymorphism in African-derived populations.
    Abou Ziki MD; Strulovici-Barel Y; Hackett NR; Rodriguez-Flores JL; Mezey JG; Salit J; Radisch S; Hollmann C; Chouchane L; Malek J; Zirie MA; Jayyuosi A; Gotto AM; Crystal RG
    Am J Cardiol; 2014 Jan; 113(2):302-8. PubMed ID: 24239320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphism.
    Martins da Fonseca CS; Pimenta Filho AA; dos Santos BS; da Silva CA; Domingues AL; Owen JS; Lima VL
    PLoS One; 2014; 9(7):e101964. PubMed ID: 25051269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive Models for the Risk of Dyslipidemia in Adolescents with Essential Arterial Hypertension.
    Kalyuzhnaya OV; Bairova TA; Kolesnikova LI
    Bull Exp Biol Med; 2018 Dec; 166(2):297-300. PubMed ID: 30488199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene-Gene Interactions of Apolipoprotein Gene Polymorphic Variants in Adolescents with Essential Arterial Hypertension and Dyslipidemia.
    Kalyuzhnaya OV; Bairova TA; Kolesnikova LI
    Bull Exp Biol Med; 2017 Aug; 163(4):456-460. PubMed ID: 28853084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.
    Wu H; Huang Q; Yu Z; Wu H; Zhong Z
    Lipids Health Dis; 2020 Sep; 19(1):202. PubMed ID: 32891149
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.